Furthermore, despite lurasidone downregulated the enzyme levels (CRS/LUR: − 21% vs. CRS, P < 0.05), it produced a small increase in Gpx1 expression in the CRS/LUR/AS group. The gene discussed is GPX1; the disease is congenital rubella syndrome.